Mode
Text Size
Log in / Sign up
N/A Completed N=1,177

"VIBRATIONS" - A Study In Smokers Who Are Willing And Motivated To Stop Smoking With The Aid Of Varenicline Which Will Be Prescribed According To Usual Clinical Practice In Germany

Source: ClinicalTrials.gov NCT01104636 ↗
Enrolled (actual)
1,177
Serious AEs
0.6%
Results posted
Feb 2012
Primary outcomePrimary: Percentage of Participants Who Abstained From Smoking at Week 12 — 71.1 percentage of participants

Summary

The aim of this study is to determine the success rates for stopping smoking with varenicline in Germany. The main measure of success will be continuous abstinence from smoking (not a single puff) in the last week of the standard 12 week treatment period. Additional information will be gathered regarding prescribing practices in Germany, smoking history, reasons why smokers quit smoking and re-start smoking, smoking related illnesses and the tolerability of varenicline.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Who Abstained From Smoking at Week 12
71.1 —
SECONDARY
Level of Nicotine Dependence Measured by the Fagerstrom Test
5.30 —

Eligibility Criteria

Inclusion Criteria

  • Legal adult age
  • Regular smoker, with main tobacco product smoked being cigarettes, and willing and motivated to stop smoking
  • Evidence of a personally signed and dated Informed Consent document.

Exclusion Criteria

  • Any subjects considered unsuitable according to the Summary of product characteristics (SmPC)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01104636). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search